We May Never Eliminate COVID-19. But We Can Learn to Live With It

When does a pandemic end? Is it when life regains a semblance of normality? Is it when the world reaches herd immunity, the benchmark at which enough people are immune to an infectious disease to stop its widespread circulation? Or is it when the disease is defeated, the last patient cured and the pathogen retired to the history books? The last scenario, in the case of COVID-19, is likely a ways off, if it ever arrives. The virus has infected more than 100 million people worldwide and killed more than 2 million. New viral variants even more contagious than those that started the pandemic are spreading across the world. And though highly effective vaccines were developed and deployed in record time, it will be a mammoth undertaking to inoculate enough of the world’s population to achieve herd immunity, especially with the new variants in hot pursuit. Already, in many countries with access to vaccines, logistical hurdles and vaccine hesitancy have proved to be formidable adversaries; meanwhile, many nations in the developing world don’t have access to vaccines at all. There have been, and will continue to be, global success stories. Israel has vaccinated a significant chunk of its population, enough to begin feasibly planning for a post-herd-immunity reality. New Zealand has effectively eliminated COVID-19 through a combination of domestic lockdowns and border-control measures, and Australia and multiple Asian countries have used similar tactics to dramatically tam...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news

Related Links:

The vaccines may well continue to ward off severe illness and death, although booster doses may be needed to protect most people. Still, the makers of the two most effective vaccines, Pfizer-BioNTech and Moderna, are preparing to reformulate their shots if necessary.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Both cases are recent arrivals from Nigeria;UN agency ’s comments follow South Africa’s call to reverse flight bans;G7 health ministers to hold urgent meeting on Omicron variantAt least 13 of 61 cases on two flights into Netherlands are new variantOmicron ’s worst impact will be in nations with low vaccination ratesWhat do we know about the new ‘worst ever’ Covid variant?See all our coronavirus coverageChina could face more than 630,000 Covid-19 infections a dayif it dropped its zero-tolerance policies by lifting travel curbs, according to a study by Peking University mathematicians, Reuters r...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: World news Coronavirus Science UK news Europe US news Source Type: news
Healthcare IT company Novarad is set to offer lung cancer screening softwar...Read more on AuntMinnie.comRelated Reading: Novarad launches new version of CryptoChart Novarad signs deal with health center in Iowa Novarad debuts free AI software for COVID-19 PenRad debuts patient notification software PenRad gives lung CT tracker to imaging centers
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Last week I described some of the reasons for using a case formulation approach when working through initial assessment information, and today I’m going to describe one approach for organising a formulation. This is the “4 P” formulation, and it’s one that’s often used in mental health (Bolton, 2014). In the 4 P model, there are four questions to ask yourself: Preconditions – Why is this person vulnerable to this problem?Precipitating factors – Why now? This can mean “why is this person having symptoms now?” or “why is this person presenting to this person ...
Source: HealthSkills Weblog - Category: Anesthesiology Authors: Tags: Assessment Chronic pain Clinical reasoning Pain conditions Professional topics Research Science in practice biopsychosocial case formulation Occupational therapy pain management Therapeutic approaches Source Type: blogs
We find out how much protection Covid vaccines may offer amid speculation new variant could be more resistantCoronavirus – latest updatesSee all our coronavirus coverageThe emergence of Omicron has prompted widespread speculation that it may be more resistant to Covid-19 vaccines than existing variants, including Delta. But what does that mean for the average double-vaccinated person?All the vaccines currently available in the UK work by training the immune system against the coronavirus spike protein – the key it uses to infect cells by binding to the ACE2 receptor. Omicron possesses more than 30 mutations in ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Vaccines and immunisation UK news Health Society Science Immunology Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Healthcare IT company Novarad is set to be the exclusive distributor of CureMetri...Read more on AuntMinnie.comRelated Reading: Novarad launches new version of CryptoChart Novarad signs deal with health center in Iowa CureMetrix appoints new executive vice president CureMetrix highlights mammo AI study results Ikonopedia partners with CureMetrix Novarad debuts free AI software for COVID-19
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Should the Omicron variant cause severe illness, that will become apparent if there is a significant rise in hospitalizations over the next week or two, one expert said.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus Omicron Variant Coronavirus (2019-nCoV) Disease Rates Vaccination and Immunization South Africa Source Type: news
He said the COVID-19 variant will "inevitably" come to the U.S. if it is not already here and warned that it is "going to have an advantage in transmissibility."
Source: Science - The Huffington Post - Category: Science Source Type: news
Thousands have rallied in the Czech capital to protest the government’s restrictive measures to tackle a record surge of coronavirus infections
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
More News: Advertising | Allergy | Allergy & Immunology | Australia Health | Boston University | Centers for Disease Control and Prevention (CDC) | Children | Common Cold | Coronavirus | COVID-19 | Endemics | Epidemiology | Flu Pandemic | Funding | Genetics | Health | Hospitals | Infectious Diseases | Influenza | Influenza Vaccine | International Medicine & Public Health | Israel Health | Learning | Lessons | Measles | Measles Vaccine | Medical Ethics | Middle East Health | Mumps | Mumps Vaccine | New Zealand Health | Outbreaks | Pandemics | Pfizer | Psychology | Rubella | Rubella Vaccine | SARS | Science | Study | Teaching | Tuberculosis | Universities & Medical Training | Vaccines | WHO